🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#CARTcells for #DIPG #DMG clinical trial (1st arm) results are out today. Full Tweetorial coming, but first want to share the story of a patient whose #DIPG has disappeared for over 3 years. It is a milestone and moment of hope on a journey filled with so much grief. “There’s a

Excited to share new study from the lab, work led by John and grateful for all the collaborators who made this possible including ChangLabUCSF UC Santa Cruz Genomics Institute

Honored to join ASCI together with many friends and dear colleagues.

Kimberly Stegmaier, MD, has been named as Pediatric Oncology Chair. She will also serve as Associate Chief of Division of Hematology/Oncology at Boston Children’s Hospital. Please join us in congratulating her on this achievement. Read more: bit.ly/3EK9Nat

We had an incredible week at The 2025 Sontag Scientific Retreat at The Ritz-Carlton, Amelia Island! We are so grateful for this supportive and collaborative community, which is essential for advancing research, discussing challenges, and making a real difference.

Dana-Farber has elected the largest cohort of physician-investigators to the 2025 class of ASCI Dana-Farber Mariella Filbin Mancias Lab OserLab Abby Rosenberg, MD, MS, MA Nilay Sethi Srinivas Viswanathan oncodaily.com/blog/dana-farb… #ASCI #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX

Biggest congratulations to an exceptional team!! Michelle Monje🎗️ 🟦

So very happy and grateful for this terrific team effort with Johannes Gojo and Carl Koschmann’s groups, and excited to move the needle for our patients! #defeatbraincancer Dana-Farber Boston Children's

1/ Thrilled to share our TWO back-to-back papers published in Nature Genetics today! nature.com/articles/s4158… , nature.com/articles/s4158…

1/ Truly excited to share our new study that I had to privilege to co-lead during my PhD alongside great friends and collaborators Masashi Nomura, Kevin C. Johnson and Luciano Garofano, which was published Nature Genetics! nature.com/articles/s4158…

Delighted to share our new study, led by @annacgeraghty and Lehi Acosta , uncovering the cellular dysregulation underpinning cognitive impairment after CAR T cell therapy and a strategy to rescue this cellular and cognitive dysfunction in mice. 1/ cell.com/cell/fulltext/…

We support all brain tumor patients and their families: past, present and future. Research is our most powerful path forward - and we are committed to advancing discoveries and delivering hope until there is a cure. #GoGrayInMay Dana-Farber/Boston Children's Dana-Farber Broad Institute

Congrats to Mariella Filbin, M.D., Ph.D., and Daniel Wahl, M.D., Ph.D.—Sontag Foundation alumni—on their induction into ASCI, honoring impactful clinical research. We also recognize Jason Huse, M.D., Ph.D., Sontag alum and past ASCI inductee, for celebrating with them.

👇🏻👇🏻A great new way to advance our field together! 💪🏻

May is Brain Cancer Awareness Month. New research from the lab of Mariella Filbin, MD, PhD, suggests that avapritinib, an FDA-approved drug used to treat GI tumors, could also treat high-grade gliomas. Learn more. bit.ly/4j7pBm3

Excited to share our new story on drivers and communication networks in a lethal tumor in young children called ETMR. Fantastic collaboration with volker hovestadt 🧬 and team! Dana-Farber Boston Children's Dana-Farber/Boston Children's Broad Institute #gograyinmay #endbraincancer 👇🏻👇🏻👇🏻

🚨 5 DAYS LEFT! The abstract submission deadline for WFNOS/SNO 2025 is THIS FRIDAY! 📅 Deadline: June 6 at 11:59 PM ET Present your research in Honolulu, Nov 19–23! Submit now: soc-neuro-onc.org/SNO2025